קסמיאול ישראל - עברית - Ministry of Health

קסמיאול

dexcel ltd - betamethasone as dipropionate 0.5 mg / 1 g; calcipotriol as hydrate 50 mcg / 1 g - gel - betamethasone - topical treatment of psoriasis vulgaris on the scalp and topical treatment of mild to moderate “non-scalp” plaque psoriasis vulgaris in adults 18 years of age and older.

קסמיאול ישראל - עברית - Ministry of Health

קסמיאול

dexcel ltd, israel - betamethasone as dipropionate; calcipotriol as hydrate - ג'ל - betamethasone as dipropionate 0.5 mg / 1 g; calcipotriol as hydrate 50 mcg / 1 g - betamethasone - betamethasone - topical treatment of psoriasis vulgaris on the scalp and topical treatment of mild to moderate “non-scalp” plaque psoriasis vulgaris in adults 18 years of age and older.

קלבמוקס 1 גרם זריקות ישראל - עברית - Ministry of Health

קלבמוקס 1 גרם זריקות

taro international ltd - amoxicillin as sodium 1 g/vial; clavulanic acid as sodium 200 mg/vial - solution for injection - amoxicillin and enzyme inhibitor - clavamox is indicated for short-term treatment of bacterial infections caused by susceptible microorganisms which are resistant to other beta-lactamase antibiotics.

קלפורן ישראל - עברית - Ministry of Health

קלפורן

sanofi - aventis israel ltd - cefotaxime as sodium 1 g - powder for solution for inj/inf - cefotaxime - severe infections caused by cefotaxime - sensitive pathogens : infections of the respiratory tract of the kidneys and urinary tract of the skin and soft tissues of the bones and joints of the genital organs including gonorrhoea and of the abdominal region. sepsis endocarditis meningitis. for preoperative prophylaxis in patients who are at increased risk from infection. for the prophylaxis of infections in patients with reduced resistance.

סנדוגלובולין 1 גרם לתוך הוריד ישראל - עברית - Ministry of Health

סנדוגלובולין 1 גרם לתוך הוריד

mediline ltd. - immunoglobulin normal human 1 g/vial - powder for solution for injection - immunoglobulins, normal human, for intravascular adm. - primary immunodeficiency (patients with primary defective antibody synthesis such as agammaglobulinaemia or hypogammaglobulinaemia). idiopathic thrombocytopenic purpura (itp).

גאמונקס  - סי ישראל - עברית - Ministry of Health

גאמונקס - סי

padagis israel agencies ltd, israel - immunoglobulins, normal human - תמיסה לאינפוזיה - immunoglobulins, normal human 0.1 g/ml - immunoglobulins, normal human, for intravascular adm. - immunoglobulins, normal human, for intravascular adm. - gamunex is indicated as replacement therapy of primary immunodeficiency (pi) states in which severe impaiment of antibody forming capacity has been shown, such as congential agammaglobulinemia, common variable immunodeficiency, x-limked immunodeficiency with hyper igm, wiskott- aldrich syndrom, and severed combined immunodeficiencies. gamunex is also indicated in idiopathic thrombocytopenia purpura (itp) to raise platelet counts to prevent bleeding or to allow a patient with itp to undergo surgery.treatment of chronic inflammatory demyelinating polyneuropathy (cidp).

סיטרבין להזרקה 1 גרם USP ישראל - עברית - Ministry of Health

סיטרבין להזרקה 1 גרם usp

genmedix - cytarabine 1 g/vial - powder for solution for injection - cytarabine - cytarabine in combination with other approved anticancer drugs is indicated for remission induction in acute non-lymphcytic leukemia of adults and children. it has also been found useful in the treatment of acute lymphocytic leukemia and the blast phase of chronic myelocytic leukemia. intrathecal administration of cytarabine is indicated in the prophylaxis and treatment of meningeal leukemia.

מדיטבין 1 גרם ישראל - עברית - Ministry of Health

מדיטבין 1 גרם

medison pharma ltd - gemcitabine as hydrochloride 1 g/vial - powder for solution for infusion - gemcitabine - palliative treatment of patients with locally advanced or metastatic non-small cell lung cancer and locally advanced or metastatic adenocarcinoma of the pancreas and for patients with 5-fu refractory pancreatic cancer. gemcitabine is indicated for the treatment of patients with bladder cancer at the invasive stage. breast cancer: gemcitabine in combination with paclitaxel is indicated for the treatment of patients with unresectable locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. prior chemotherapy should have included an anthracycline unless clinically contraindicated. ovarian cancer: gemcitabine in combination with carboplatin is indicated for the treatment of patients with recurrent epithelial ovarian carcinoma whom have relapsed at least six months after platinum - based therapy.

מדיטבין 1 גרם ישראל - עברית - Ministry of Health

מדיטבין 1 גרם

medison pharma ltd - gemcitabine as hydrochloride 1 g/vial - powder for solution for infusion - gemcitabine - palliative treatment of patients with locally advanced or metastatic non-small cell lung cancer and locally advanced or metastatic adenocarcinoma of the pancreas and for patients with 5-fu refractory pancreatic cancer. gemcitabine is indicated for the treatment of patients with bladder cancer at the invasive stage. breast cancer: gemcitabine in combination with paclitaxel is indicated for the treatment of patients with unresectable locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. prior chemotherapy should have included an anthracycline unless clinically contraindicated. ovarian cancer: gemcitabine in combination with carboplatin is indicated for the treatment of patients with recurrent epithelial ovarian carcinoma whom have relapsed at least six months after platinum - based therapy.

אופטלגין זריקות ישראל - עברית - Ministry of Health

אופטלגין זריקות

teva pharmaceutical indust.ltd - dipyrone 1 g / 2 ml - solution for injection - metamizole sodium - as an analgesic: optalgin injection, by intravenous administration, is indicated for the relief of severe and acute pain when oral treatment is not feasible or suitable, as in post-traumatic or post-surgical pain, biliary or renal colic, and pain associated with malignant diseases. intravenous administration of dipyrone should be carried out slowly over a period of at least 5 minutes, followed by reasonable clinical observation. intramuscular administration of dipyrone for relief of pain is not recommended.however, if medical circumstances require such administration, all due precautions should be exercised to permit reasonable clinical observation. as an antipyretic: optalgin injection by intramuscular administration is indicated to lower temperature in life-threatening situations, when this cannot be achieved by other means. hyperthermic patients in critical condition may also be treated in non-hospital environment, under close medical supervision.